Physician profile
Ashley L Taylor
NPI 1447654306
$599.60
in general payments reported to CMS, 2019-2025
17 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.08 · 2023: $72.04 · 2024: $181 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $159.32 | 2023-2025 | Carvykti, Rybrevant, Erleada |
| Boston Scientific Corporation | $90.13 | 2024 | |
| Medtronic, INC. | $43.21 | 2022-2023 | Interstim |
| Immunitybio, INC. | $38.94 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.42 | 2024-2025 | Lynparza |
| Antares Pharma, INC. | $34.20 | 2025 | Xyosted |
| Dendreon Pharmaceuticals LLC | $26.62 | 2024 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $20.37 | 2025 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Sumitomo Pharma America, INC. | $19.97 | 2025 | Gemtesa |
| Kci USA, INC. | $19.65 | 2022 | |
| Endo Pharmaceuticals INC. | $17.92 | 2023 | Aveed, Xiaflex |
| Ferring Pharmaceuticals INC. | $16.10 | 2024 | Adstiladrin |
| Urogen Pharma, INC. | $15.93 | 2025 | |
| Astellas Pharma US INC | $15.76 | 2024 | Xtandi |
| 180 Medical, INC. | $15.51 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.39 | 2024 | |
| Pfizer INC. | $15.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.